Monday, March 10, 2014

Smart Phones and Not So Smart Parenting

Smart Phones and Not So Smart Parenting, health, medpagetodayUsing a mobile device during meals in fast-food restaurants made caregivers less attentive to the small children they were with, researchers reported.

Friday, March 7, 2014

Vitamin D Increases Breast Cancer Patient Survival

Vitamin D Increases Breast Cancer Patient Survival, health Breast cancer patients with high levels of vitamin D in their blood are twice as likely to survive the disease as women with low levels of this nutrient, report University of California, San Diego School of Medicine researchers in the March issue of Anticancer Research.

Wednesday, March 5, 2014

#Doodle4Google contest: Artists talk about judging — and winning — ahead of today’s virtual tour for students

Doodle 4 Google contest: Artists talk about judging — and winning — ahead of today’s virtual tour for students

“I love that one open-ended Doodle 4 Google theme can inspire so many thousands of drastically different and wild entries,” Google artist and judge Sophie Diao tells The Post.

Tuesday, March 4, 2014

Free Pancakes At IHOP For #NationalPancakeDay

Free Pancakes At IHOP For #NationalPancakeDay

If ‘Fat Tuesday’ was not tempting enough for you, then IHOP’s National Pancake Day with FREE pancakes should seduce your palette and your wallet.

Monday, March 3, 2014

Oscar Script Win for ’12 Years A Slave’ Completes Two-Decade Journey for John Ridley

12 Years a Slave, Academy Awards, John Ridley, Oscar Script Win for ’12 Years A Slave’ Completes Two-Decade Journey for John Ridley

John Ridley’s Oscar win for adapted script for “12 Years a Slave” culminates more than two decades in Hollywood for the Milwaukee-born writer.

Baby 'Sleep Machines' Could Damage Hearing: Study

Baby 'Sleep Machines' Could Damage Hearing: Study, HealthDay News
(HealthDay News) -- Some of the "sleep machines" marketed to soothe infants seem capable of generating enough noise to potentially damage a baby's hearing, a new study suggests.

Monday, February 3, 2014

Ablynx agrees Merck cancer deal worth up to 1.7 billion euros

Ablynx agrees Merck cancer deal worth up to 1.7 billion euros, health, cancer BRUSSELS (Reuters) - Belgian biotech company Ablynx has signed a deal with Merck & Co worth up to 1.7 billion euros ($ 2.3 billion) to develop ways of triggering the body to fight cancer by itself.